| Document Date: 2013-12-16 11:51:54
Open Document File Size: 292,52 KBShare Result on Facebook
City Rostock / Oxford / / Country United States / Netherlands / Australia / United Kingdom / / Event Product Issues / / Facility Laboratory facility / Each laboratory / / IndustryTerm suitable barrier systems / manufacturing staff / manufacturing environment / pharmaceutical / pharmaceutical industries / conventional technology / inserted gene product / manufacturing plants / / MarketIndex IVP / / MedicalCondition epidemic threat / related microorganisms Influenza viruses / productive infection / wild-type human influenza virus / animal influenza viruses / pathogenic traits The influenza HA / lethal mouse infection / human H5N1 infections / human influenza A / human influenza virus / human influenza viruses / epidemic activity / mixed infection / highly pathogenic influenza virus / fatal systemic infection / avian influenza viruses / recipient virus The recipient influenza virus / influenza A / human infection / influenza virus infection / necessary Influenza viruses / infectious / fever / lethargy / H5N1 influenza viruses / influenza viruses / avian influenza / H7 influenza A / pandemic influenza / avian and human influenza virus / highly pathogenic avian influenza viruses / H5N1 infections / whole influenza / infection / localized non-pathogenic infection / highly pathogenic human infection / H5N1 avian virus infection / influenza virus / illness / inactivated influenza / infections / human H7N7 infections / egg infectious doses / influenza / conventional influenza / / Organization World Health Organization / DEPARTMENT OF COMMUNICABLE DISEASE SURVEILLANCE AND RESPONSE WHO Global Influenza Programme Production / / Product faeces / / RadioStation 2003 WHO / / Technology cell receptors / genotype / /
SocialTag |
Microsoft Word - influenza_risk_112003.doc